B. Weiner David's Insider Trades & SAST Disclosures
B. Weiner David's most recent trade in Inovio Pharmaceuticals Inc was a trade of 972 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern B. Weiner David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 84,453 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 972 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 972 | 83,481 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 82,509 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
B. David Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David Weiner B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 79,371 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
Weiner B. David | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 80,343 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
B. Weiner David | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 972 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David Weiner B. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 1,944 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 972 | 78,399 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 929,124 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 11,666 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 11,666 | 915,957 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 11 Mar 2023 | 5,833 | 910,124 (0%) | 0% | 1.2 | 6,708 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 60,000 | 60,000 | - | - | Common Stock Option | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 26 Feb 2023 | 11,668 | 904,291 (0%) | 0% | 1.3 | 14,935 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 23,333 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 11,666 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 915,959 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2023 | 11,667 | 904,292 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 11,875 | 11,875 | - | - | Common Stock Option | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 11 Aug 2022 | 11,875 | 892,625 (0%) | 0% | 2.7 | 31,588 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.16 per share. | 11 Aug 2022 | 11,875 | 904,500 (0%) | 0% | 2.2 | 25,650 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 901,625 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 13 May 2022 | 9,000 | 892,625 (0%) | 0% | 2.0 | 17,550 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 11,667 | 11,666 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 11,667 | 887,708 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 3.20 per share. | 11 Mar 2022 | 4,083 | 883,625 (0%) | 0% | 3.2 | 13,066 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 11,666 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 11,666 | 880,124 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Sale of securities on an exchange or to another person at price $ 3.33 per share. | 08 Mar 2022 | 4,083 | 876,041 (0%) | 0% | 3.3 | 13,596 | Common Stock |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 60,000 | 60,000 | - | - | Common Stock Option | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 11,667 | 23,333 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 11,667 | 868,458 (0%) | 0% | - | Common Stock | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
|
Inovio Pharmaceuticals Inc
|
David B. Weiner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 859,836 (0%) | 0% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges